AWARD
99 -- Broad Agency Announcement for the Advanced Development of Medical Countermeasures for Pandemic Influenza
- Notice Date
- 6/1/2015
- Notice Type
- Award Notice
- Contracting Office
- Department of Health and Human Services, Office of the Secretary, Acquisitions Management, Contracts, & Grants (AMCG), Office of the Assistant Secretary for Preparedness & Response (ASPR), Department of Health and Human Services, 330 Independence Ave. SW, G640, Washington, District of Columbia, 20201, United States
- ZIP Code
- 20201
- Solicitation Number
- BAA-13-100-SOL-00019
- Archive Date
- 6/6/2015
- Point of Contact
- Kevin Nilles,
- E-Mail Address
-
kevin.nilles@hhs.gov
(kevin.nilles@hhs.gov)
- Small Business Set-Aside
- N/A
- Award Number
- HHSO100201500010C
- Award Date
- 5/22/2015
- Awardee
- GlaxoSmithKline LLC
- Award Amount
- $79,998,267 base period; either a $120,000,000 or $112,000,344 option period
- Description
- Contract No. HHSO100201500010C was awarded on May 22, 2015 to GlaxoSmithKline LLC in the amount of $79,998,267 for the base period and either a $120,000,000 or $112,000,344 option period to support the development of cell-based influenza virus vaccines against influenza subtypes with pandemic potential.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/OOS/OASPHEP/BAA-13-100-SOL-00019/listing.html)
- Record
- SN03748904-W 20150603/150601235309-93a2aebb97b43759526367a401e42aa3 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |